According to market research study published by Gen Consulting Company, the market size of the global smart insulin pens sector is expected to rise by USD 73 million with a CAGR of 10.3% by the end of 2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global smart insulin pens market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the smart insulin pens industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 分销渠道, 和地区. The global market for smart insulin pens can be segmented by product: connecting device, smart pen. Smart insulin pens market is further segmented by distribution channel: hospitals and pharmacies, 在线的. 根据地区, the smart insulin pens market is segmented into: 北美, 亚太地区, 欧洲, 世界其他地区 (ROW).

副产品:
– connecting device
– smart pen

By distribution channel:
– hospitals and pharmacies
– 在线的

按地区:
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (ROW)

The report has also analysed the competitive landscape of the global smart insulin pens market with some of the key players being Companion Medical, 公司. (Medtronic plc), Diamesco Co., 有限公司, Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH E-Health Technologies, Novo Nordisk A/S, pendiq GmbH, Ypsomed Holding AG, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global smart insulin pens market.
– To classify and forecast the global smart insulin pens market based on product, 分销渠道, 地区.
– To identify drivers and challenges for the global smart insulin pens market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global smart insulin pens market.
– To identify and analyze the profile of leading players operating in the global smart insulin pens market.

为什么选择这份报告
– Gain a reliable outlook of the global smart insulin pens market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.